M. Solèr

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, Jonathan Matz, Robert G. Townley et al. · European Respiratory Journal · 2001 · 826 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Exercise Capacity as a Predictor of Postoperative Complications in Lung Resection Candidates

Chris T. Bolliger, Peter J. Jordan, M. Solèr et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 250 citations

Medicine, Perioperative Medicine, Surgery +16

Pulmonary function and exercise capacity after lung resection

CT Bolliger, Peter J. Jordan, M. Solèr et al. · European Respiratory Journal · 1996 · 210 citations · Full text

Medicine, Surgery, Exercise Testing +16

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma

Roland Buhl, M. Solèr, Jonathan Matz et al. · European Respiratory Journal · 2002 · 180 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma

Roland Buhl, G. Hanf, M. Solèr et al. · European Respiratory Journal · 2002 · 158 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17